Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC6 pseudogene 4 (TRPC6P4) is a non-protein-coding pseudogene related to the TRPC6 gene family. Pseudogenes are segments of DNA resembling functional genes but are typically nonfunctional due to mutations, deletions, or insertions that prevent protein expression. Unlike the functional TRPC6 gene, which encodes a calcium-permeable ion channel implicated in podocyte biology, immune signaling, and cardiovascular disease, TRPC6P4 does not encode an active ion channel and is not considered a therapeutic or molecular target. While "TRPC6" refers to the *Transient receptor potential cation channel subfamily C member 6*—a well-studied ion channel and a bona fide therapeutic target in kidney and cardiovascular diseases[1][2][4][5][7]—the suffix “pseudogene 4” clearly indicates that TRPC6P4 represents a non-coding, likely non-functional genomic element. Pseudogenes are not classified as receptors, enzymes, transporters, transcription factors, or any conventional molecular target classes. There is no evidence in scientific literature or bioinformatics databases that TRPC6P4 has functional protein product, biological function, disease association, or interacts with drugs. Its presence in genomic annotations typically serves as a reference for evolutionary or transcriptomic studies rather than therapeutic development. TRPC6 pseudogene 4 (TRPC6P4) is not a molecular target and should not be considered for target-based research or drug development. “TRPC6” (without the pseudogene designation) is the canonical reference for the functional protein-coding gene and relevant therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPC6 pseudogene 4 (TRPC6P4).